Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii

Vaccine

Volumn 26, Issue 31, 2008, Pages 3913-3921

  Cong, Hua ^a   Gu, Qin Min ^a   Yin, Hong En ^b   Wang, Jing Wen ^c   Zhao, Qun Li ^a   Zhou, Huai Yu ^a   Li, Ying ^a   Zhang, Jia Qin ^a  

^a SHANDONG UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c Shandong Institute of Medicine and Health Information   (China)

Author keywords

Cholera toxin; DNA vaccine; Multi epitope; Toxoplasma gondii

Indexed keywords

CHOLERA TOXIN; CHOLERA TOXIN A2 SUBUNIT; CHOLERA TOXIN B SUBUNIT; DNA VACCINE; EPITOPE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SYNTHESIS; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; BASE SEQUENCE; CHOLERA TOXIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GENETIC VECTORS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMIDS; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, DNA;

EID: 46349102408     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.046     Document Type: Article

References (50)

1. Jeffrey D.K., and Daniel G.F. Toxoplasmosis in pregnancy. Am J Med 118 (2005) 212-216
2. McLeod R., Boyer K., Roizen N., Stein L., Swisher C., Holfels E., et al. The child with congenital toxoplasmosis. Curr Clin Top Infect Dis 20 (2000) 189-208
3. Irene L., Deogratias H.K., Fred K., and Johan L. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda. Acta Trop 100 (2006) 218-222
4. David B., Stephen W.M., Steve E.W., Susan R., Paul B., and Elisabeth A.I. Toxoplasma gondii and ovine toxoplasmosis: new aspects of an old story. Vet Parasitol 149 (2007) 25-28
5. Dubey J.P., Buxton D., and Wouda W. The pathogenesis of bovine neosporosis. J Comp Pathol 134 (2006) 267-289
6. Alexander J., Jebbari H., Bluethmann H., Satoskar A., and Roberts C.W. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr Top Microbiol Immunol 219 (1996) 183-195
7. Rabie M.M., Fumie A., Mei C., Hye-Seong M., Kazumi N., Usama S.B., et al. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 21 (2003) 2852-2861
8. Sette A., Livingston B., Mckinney D., Appella E., Fikes J., Sidney J., et al. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. Biologicals 29 (2001) 271-276
9. Beghetto E., Nielsen H.V., Porto P.D., Buffolano W., Guglietta S., Felici F., et al. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis 191 (2005) 637-645
10. Mevelec M.N., Bout D., Desolme B., Marchand H., Magne R., Bruneel O., et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23 (2005) 4489-4499
11. Burg J.L., Perelman D., Kasper L.H., Ware P.L., and Boothroyd J.C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol 141 (1988) 3584-3591
12. Angus C.W., Klivington-Evans D., Dubey J.P., and Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1(p30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 181 (2000) 317-324
13. Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., et al. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitol Res 88 (2002) 144-149
14. Leyva R., Herion P., and Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of T. gondii. Parasitol Res 87 (2001) 70-79
15. Darcy F., Deslee D., Santoro F., Chariault C., Decoster A., Duquesne V., et al. Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoite of Toxoplasma gondii. Parasite Immunol 10 (1988) 553-567
16. Lunden A. Immune response in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. Vet Parasitol 56 (1995) 23-35
17. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., and Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 67 (1999) 6356-6363
18. Godard I., Estaquier J., Zenner L., Bossus M., Auriault C., Darcy F., et al. Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Mol Immunol 31 (1994) 1353-1364
19. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from T. gondii p30 antigen. J Immunol 149 (1992) 3636-3647
20. Zenner L., Estaquier J., Darcy F., Maes P., Capron A., and Cesbron-Delauw M.F. Protective immunity in the rat model of congenital toxoplasmosis and the potential vaccine role of excreted/secreted antigens. Parasite Immunol 21 (1999) 261-272
21. Nielsen H.V., Cristina M.D., Beghetto E., Spadoni A., Petersen E., and Gargano N. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Exp Parasitol 112 (2006) 274-279
22. Bivas-Benita M., Laloup M., Versteyhe S., Dewit J., Braekeleer J.D., Jongert E., et al. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharmaceut 266 (2003) 17-27
23. Mevelec M.N., Chardes T., Mercereau-Puijalon O., Bourguin I., Achbarou A., Dubremetz J.F., et al. Molecular cloning of GRA4, a Toxoplasma dense granule protein recognized by mucosal IgA antibodies. Mol Biochem Parasitol 56 (1992) 227-238
24. Duquesne V., Auriault C., Gras-Masse H., Boutillon C., Darcy F., et al. Identification of T cell epitope within a 23-kDa antigen (P24) of Toxoplasma gondii. Clin Exp Immunol 84 (1991) 527-534
25. Beghetto E., Spadoni A., Buffolano W., Pezzo M.D., Minenkova O., Pavoni E., et al. Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int J Parasitol 33 (2003) 163-173
26. Chardes T., Bourguin I., Mevelec M.N., Dubremetz J.F., and Bout D. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect Immun 58 (1990) 1240-1246
27. Meisel R., Stachelhaus S., Mevelec M.N., Reichmann G., Dubremetz J.F., and Fischer H.G. Identification of two alleles in the GRA4 locus of Toxoplasma gondii determining a differential epitope which allows discrimination of type I versus type II and III strains. Mol Biochem Parasitol 81 (1996) 259-263
28. Nakaar V., Ngo H.M., Aaronson E.P., Coppens I., Stedman T.T., and Joiner K.A. Pleiotropic effect due to targeted depletion of secretory rhoptry protein ROP2 in Toxoplasma gondii. J Cell Sci 116 (2003) 2311-2320
29. Saavedra R., Becerril M.A., Dubeaux C., Lippens R., De vos M.J., Herion P., et al. Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect Immun 64 (1996) 3858-3862
30. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J Immunol 175 (2005) 633-639
31. Yang W., Jackson D.C., Zeng Q.R., and McManus D.P. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice. Vaccine 19 (2001) 103-113
32. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186 (1997) 1623-1631
33. Bromandeer A., Holmgren J., and Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol 146 (2000) 2908-2914
34. McCluskie M.J., Weeratna R.D., Clements J.D., and Davis H.L. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants. Vaccine 19 (2001) 3759-3768
35. Gong L., Zhang B., Zhang Y., Hu H.Y., Zhao Z.Y., Liu X.X., et al. expression and purification of human s-adenosylmethionine decarboxylase gene α subunit. Chin J Physiol 50 (2007) 29-33
36. Ma C.H., Zhang Y., Wang X.Y., Gao L.F., Liu H., Guo C., et al. Human endostatin gene transfer, either naked or with liposome, has the sameinhibitory effect on growth of mouse liver tumor cells in vivo. World J Gastroenterol 10 (2004) 2874-2877
37. Jiang Y., and Gu Q.M. The construction of an eukaryotic expression plasmid encoding Toxoplasma gondii multi-antigenic gene P30, P22 and A2/B genes of cholera toxin. J Trop Dis Parasitol 2 (2004) 76-80
38. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21 (2003) 1327-1335
39. Girish M.B. Development of a vaccine for toxoplasmosis: current status. Microb Infect 5 (2003) 457-462
40. Patarroyo M.E., Cifuentes G., and Rodriguez R. Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine. Int J Biochem Cell Biol 40 (2008) 543-557
41. Cai Q.L., Peng G.Y., Bu L.Y., Lin Y.H., Zhang L.H., Lustigmen S., et al. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Vaccine 25 (2007) 5155-5165
42. Livingston B.D., Newman M., Crimi C., Mckinney D., Chesnut R., and Sette A. Optimization of epitope processing enhances immunogenicity of vaccines. Vaccine 19 (2001) 4652-4660
43. Khan M.A.H., Ogita K., Ferro V.A., Kumasawa K., Tsutsui T., and Kimura T. Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility. Vaccine 26 (2008) 1365-1374
44. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., et al. Immostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273 (1996) 352-354
45. Moldoveanu Z., Love-Homan L., Huang W.Q., and Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16 (1998) 1216-1224
46. George-Chandy A., Eriksson K., Lebens M., Nordstrom I., Schon E., and Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69 (2001) 5716-5725
47. Cong H., Gu Q.M., Jiang Y., He S.Y., Zhou H.Y., Li Y., et al. Oral immunization with recombinant attenuated Salmonella protect mice against Toxopalsma gondii. Parasite Immunol 27 (2005) 29-35
48. Lycke N. The mechanism of cholera toxin adjuvanticity. Res Immunol 148 (1997) 504-520
49. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T cell mediated immunity during Toxoplasma gondii infection. Clin Microbiol 11 (1998) 569-588
50. Johnson L.L., Lanthier P., Hoffman J., and Chen W.X. Vaccination protections B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii. Vaccine 22 (2004) 4054-4061